post-finasteride syndrome | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

54,423 results for “post-finasteride syndrome”

Global Study Links Hair Loss Drug Finasteride to Increased Suicide Risk and Depression

EMA Reviews Finasteride and Dutasteride Hair Loss Drugs Over Suicidal Ideation Concerns

FDA Warns of Serious Side Effects from Unapproved Topical Finasteride Hair Loss Treatments

Grifols' Immunoglobulin Therapy Shows Promising Results in Post-Polio Syndrome Clinical Trial

MHRA Strengthens Safety Warnings for Finasteride and Dutasteride Over Psychiatric and Sexual Side Effects

Immunic's IMU-838 Enters Phase 2 Trial for Post-COVID Syndrome

NIH-Sponsored Trial Shows Stent Placement Significantly Reduces Post-Thrombotic Syndrome Severity

EU Regulator Confirms Suicidal Thoughts as Rare Side Effect of Hair Loss Drug Finasteride

Phase 3 FINESSE Trial Launches to Evaluate Finasteride in Prostate Cancer Active Surveillance

Experimental Celiac Drug Shows Promise in Treating Children with Post-COVID Inflammatory Syndrome

Page 1 of 745